Interleukin 4 and interleukin 13 inhibition: A promising therapeutic approach in bullous pemphigoid

Shamir Geller

Research output: Contribution to journalEditorial

Original languageEnglish
Pages (from-to)37-38
Number of pages2
JournalJournal of the American Academy of Dermatology
Volume83
Issue number1
DOIs
StatePublished - Jul 2020

Keywords

  • antibody
  • bullous pemphigoid
  • dupilumab

Cite this